VYNE Therapeutics CEO David Domzalski receives $2.9M in 2020
VYNE Therapeutics reports 2020 executive compensation
By ExecPay News
Published: June 7, 2021
VYNE Therapeutics reported fiscal year 2020 executive compensation information on June 7, 2021.
In 2020, four executives at VYNE Therapeutics received on average a compensation package of $1.7M, a 42% increase compared to previous year.
Average pay of disclosed executives at VYNE Therapeutics
David Domzalski, Chief Executive Officer, received $2.9M in total. 46% of Domzalski's compensation, or $1.3M, was in stock awards. Domzalski also received $277K in bonus, $757K in option awards, $501K in salary, as well as $11K in other compensation.
Steven Basta, Chief Executive Officer, received a compensation package of $1.6M, which decreased by 14% compared to previous year. 89% of the compensation package, or $1.4M, was in other compensation.
Andrew Saik, Chief Financial Officer, earned $1.5M in 2020.
Mutya Harsch, Chief Legal Officer, received $907K in 2020.
Related executives
You may also like
Source: SEC filing on June 7, 2021.